Agilon Health, Inc. Hits New 52-Week High at $104.00

Agilon Health, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 104.00 on June 9, 2026. This achievement marks a remarkable performance over the past year, with the stock soaring by an impressive 1424.78%, significantly outpacing the S&P 500's growth of 22.99% during the same period. With a market capitalization of USD 164 million, Agilon Health operates in a competitive industry characterized by rapid innovation and evolving market dynamics. Despite its recent stock performance, the company remains in a loss-making position, as indicated by its negative price-to-earnings ratio and return on equity. The stock's price-to-book ratio stands at 1.30, reflecting its valuation relative to its net assets. Investors and market observers will be keen to monitor how Agilon Health navigates its current position in the market following this notable price achievement. The company's journey in the pharmaceuticals and biotechnology landscape continues to unfold as it reaches new heights.